-

Trinity Life Sciences Launches Portfolio of Omnichannel Promotional Excellence Offerings

Upcoming Webinar “A Practical Omnichannel Vision: From Strategy to Execution and Optimization” Discusses What Dynamics Life Sciences Organizations Should Consider in Advancing Omnichannel Capabilities

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces Trinity Omnichannel Promotional Excellence, a suite of scalable solutions for commercial life sciences teams focused on planning, executing and optimizing omnichannel initiatives. The portfolio includes technology, analytics, data science and business intelligence tools and services that address multiple life sciences omnichannel needs.

Omnichannel promotion in life sciences encompasses sales and marketing activity across multiple digital and personal channels including email, web and mobile content, rep interactions, webinars, HCP speaker programs and more. Successful omnichannel promotion involves coordinated exposure to marketing interactions across multiple journeys, tactics, messages, channels and partners to optimize audience engagement. Brand, Marketing and Commercial Operations leaders are often challenged by the complex, inherently technical strategy and tactics that make the omnichannel vision real.

The Trinity Omnichannel Promotional Excellence portfolio includes technology and services that allow life sciences commercial teams to establish a strategy and structure to support omnichannel, execute on that strategy and then continuously measure and optimize:

Strategy & Structure

  • Roadmaps and playbooks to help achieve a brand’s strategic promotional imperatives
  • Data management platforms that integrate commercial data sets for use in downstream analytics and applications
  • Fundamental data strategy and infrastructure to build and fully utilize more complex long-term initiatives

Execution

  • Orchestration of digital and personal touchpoints (e.g., Next Best Action, Dynamic Targeting, Alerts)
  • Simulation and optimization tools to evaluate channel and investment mix scenarios

Measurement & Optimization

  • Customer engagement and campaign performance tracking
  • Industry benchmarks from TGaS Advisors, a division of Trinity, to enhance marketplace understanding, justify changes in investment and assess not only how each channel performs—but how that performance compares with peers
  • Analysis of all personal and digital promotional channels, including individual campaigns to guide future investment decisions and maximize ROI

“Omnichannel initiatives in life sciences often drive concerns of overspending, difficulties in achieving ROI and overdeploying solutions. Limited adoption by field teams not trusting and dismissing initiatives like Next Best Action is also common,” explains Susheel Sukhtankar, Partner and Head of Commercial Analytics at Trinity Life Sciences. “Establishing and optimizing omnichannel promotional efforts are inarguably complicated initiatives—but the rewards are immense for life sciences companies, and for their customers.”

“It’s critical to think of how omnichannel impact will scale across the organization—cross-functional collaboration and alignment is needed, and so is a focus on change management,” added Neal Dunn, Senior Partner and Head of Analytics at Trinity Life Sciences. “Trinity’s Omnichannel Promotional Excellence portfolio was built by experts to support these organizational paradigm shifts by providing a comprehensive, data-driven view of omnichannel analytics.”

A webinar, A Practical Omnichannel Vision: From Strategy to Execution and Optimization, on May 18 will feature perspectives on designing, implementing, measuring and optimizing within an omnichannel framework.

Life sciences executives can register here.

Members of the media who would like to attend the webinar can contact Elizabeth Marshall at emarshall@trinitylifesciences.com.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With over 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom